Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis

European Respiratory Journal

Volumn 27, Issue 3, 2006, Pages 451-459

  Idali, Farah ^a   Wiken M ^a   Wahlstrom J ^a   Mellstedt, H ^a   Eklund, A ^a   Rabbani, H ^a   Grunewald, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bronchoalveolar lavage; Cytokine; Interferon ; Sarcoidosis; Tumour necrosis factor

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMETRY; DISEASE COURSE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG; LUNG ALVEOLUS CELL; LUNG FLUID; LUNG LAVAGE; LUNG SARCOIDOSIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SCANDINAVIA; SMOKING; TH1 CELL;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS, PULMONARY; TH1 CELLS;

EID: 33644867204     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00067105     Document Type: Article

References (32)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
2. Muller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12: 716-738.
3. Wahlstrom J, Katchar K, Wigzell H, Olerup O, Eklund A, Grunewald J. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 2001; 163: 115-121.
4. Lenz AG, Hinze-Heyn H, Schneider A, et al. Influence of inflammatory mechanisms on the redox balance in interstitial lung diseases. Respir Med 2004; 98: 737-745.
5. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983; 308: 793-800.
6. Minshall EM, Tsicopoulos A, Yasruel Z, et al. Cytokine mRNA gene expression in active and nonactive pulmonary sarcoidosis. Eur Respir J 1997; 10: 2034-2039.
7. Shigehara K, Shijubo N, Ohmichi M, et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 2001; 166: 642-649.
8. Barbarin V, Petrek M, Kolek V, Van Snick J, Huaux F, Lison D. Characterization of p40 and IL-10 in the BALE of patients with pulmonary sarcoidosis. J Interferon Cytokine Res 2003; 23: 449-456.
9. Homolka J, Muller-Quernheim J. Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis. Lung 1993; 171: 173-183.
10. Terao I, Hashimoto S, Horie T. Effect of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis. Int Arch Allergy Immunol 1993; 102: 242-248.
11. Strausz J, Mannel DN, Pfeifer S, Borkowski A, Ferlinz R, Muller-Quernheim J. Spontaneous monokine release by alveolar macrophages in chronic sarcoidosis. Int Arch Allergy Appl Immunol 1991; 96: 68-75.
12. Zissel G, Homolka J, Schlaak J, Schlaak M, Muller-Quernheim J. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am J Respir Crit Care Med 1996; 154: 713-719.
13. Hedfors E, Lindström F. HLA-B8/DR3 in sarcoidosis: correlation to acute onset disease with arthritis. Tissue Antigens 1983; 22: 200-203.
14. Gardner J, Kennedy HG, Hamblin A, Jones E. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax 1984; 39: 19-22.
15. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997, 156: 1601-1605.
16. Grunewald J, Olerup O, Persson U, Ohrn MB, Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA 1994; 91: 4965-4969.
17. Grunewald J, Wahlstrom J, Berlin M, Wigzell H, Eklund A, Olerup O. Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax 2002; 57: 348-352.
18. Texier C, Pouvelle-Moratille S, Busson M, Menez AB. Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules. Eur J Immunol 2001; 31: 1837-1846.
19. Eklund A, Blaschke E. Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. Thorax 1986; 41: 629-634.
20. Wahlstrom J, Dahlen B, Ihre E, Wigzell H, Grunewald J, Eklund A. Selective CD8+ T cells accumulate in the lungs of patients with allergic asthma after allergen bronchoprovocation. Clin Exp Immunol 1998; 112: 1-9.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
22. Perkin-Elmer Instruction manual. User Bulletin no. 2. Foster City, CA, USA, Perkin-Elmer Applied Biosytem Inc., 1997; pp. 1-36.
23. Olerup OH. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-235.
24. Moller DR, Forman JD, Liu MC, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996; 156: 4952-4960.
25. Hauber HP, Gholami D, Meyer A, Pforte A. Increased interleukin-13 expression in patients with sarcoidosis. Thorax 2003; 58: 519-524.
26. Kaneshima H, Nagai S, Shimoji T, et al. TNF alpha mRNA, but not IL-1 beta, is differentially expressed in lung macrophages of patients with active pulmonary sarcoidosis. Sarcoidosis 1994; 11: 19-25.
27. Myatt N, Coghill G, Morrison K, Jones D, Cree IA. Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation. J Clin Pathol 1994; 47: 423-426.
28. Raychaudhuri B, Fisher CJ, Farver CF, et al. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine 2000; 12: 1348-1355.
29. Chensue SW, Ruth JH, Warmington K, Lincoln P, Kunkel SL. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J Immunol 1995; 155: 3546-3551.
30. Nash JR, McLaughlin PJ, Hoyle C, Roberts D. Immunolocalization of tumour necrosis factor alpha in lung tissue from patients dying with adult respiratory distress syndrome. Histopathology 1991; 19: 395-402.
31. Carter JD, Ghio AJ, Samet JM, Devlin RB. Cytokine production by human airway epithelial cells after exposure to an air pollution particle is metal-dependent. Toxicol Appl Pharmacol 1997; 146: 180-188.
32. Neff SB, Roth Z'graggen B, Neff TA, et al. Inflammatory response of tracheobronchial epithelial cells to endotoxin. Am J Physiol Lung Cell Mol Physiol 2006; 290: L86-L96.